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Objectives The goal of this study was to prospectively assess blood pressure (BP) and echocardio-
graphic parameters to delineate the incidence and nature of the hypertension burden in this cohort.
Background Few data are available on the long-term outcomes of aortic stenting.
Methods Thirty-one patients with successfully stented coarctation during childhood (mean age 12.4
years) underwent 24-h ambulatory BP monitoring (ABPM), exercise BP measurement, and echocar-
diographic assessment.
Results Mean time after stent implantation was 5.3  4 years. Hypertension was noted on one-off
right-arm BP assessment in 3 patients (10%), but on the basis of the 24-h ABPM assessment in 14
patients (45%). Twenty-four of 31 patients (80%) had an abnormally elevated exercise BP response.
Peak exercise BP correlated with left ventricular mass index (r  0.51; p  0.05), which was also sig-
iﬁcantly increased in the entire cohort (mean  91.3 g/m2; p  0.05). In patients with signiﬁcant
omatic growth since implantation, the indexed diameter of the stent (to aortic diameter) had sig-
iﬁcantly decreased from the 48th percentile at the implantation to the 4th percentile during the
tudy (p  0.05). There was no difference in any parameter between patients with native or those
ith recurrent coarctation.
onclusions Hypertension is endemic in patients with stented coarctation, irrespective of the ab-
ence of residual obstruction. Due to abnormal BP homeostasis, hypertension should be aggressively
ursued by ABPM assessment and exercise stress testing in this population. Relative hypoplasia of
he stented arch after somatic growth may contribute to this tendency and should provoke consider-
tion of elective serial redilation of coarctation stents. (J Am Coll Cardiol Intv 2013;6:192–201) © 2013 by the
merican College of Cardiology Foundation
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193Coarctation of the aorta (CoA) accounts for 5% to 8% of all
congenital heart lesions presenting in infancy (1). Since the
first surgical correction in 1944, numerous treatment strat-
egies have been described and tested to relieve the arch
obstruction (2,3). In the last 2 decades, percutaneous ap-
proaches have attained clinical prominence with excellent
short-term clinical outcomes (3–6). A comprehensive un-
derstanding of the pathophysiology after arch repair, in
regard to intrinsic systemic vascular abnormalities and blood
pressure (BP) homeostasis is in its infancy. Multiple studies
have shown abnormal responses to exercise in all age groups
whether addressed surgically or by stent or balloon dilation.
However, the clinical significance of these abnormal re-
sponses has not been fully characterized (7–12).
Although several authors have assessed resting, ambula-
tory, and exercise BP response, few studies have prospec-
tively assessed a cohort to determine the longer-term impact
on cardiovascular physiology (13,14). Thus, the goals of this
study were first to delineate the incidence of hypertension
through analysis of multiple BP parameters at medium- to
long-term follow-up after successful stent implantation, and
second, to identify patient and treatment characteristics that
may be associated with an increased hypertensive burden.
Methods
Study design. One hundred ten children were identified
from the cardiac interventional database that had stent
implantation for CoA at age18 years, between September
1995 and November 2009. Indications for stent implanta-
tion were a cuff systolic upper-to-lower limb BP gradient of
20 mm Hg with angiographic confirmation of the lesion,
either a recurrent (reCoA) or so-called native (naCoA)
obstruction in the isthmus region of the aorta. From this
population, 41 children had a previous surgical repair with
reCoA and 69 had an naCoA. Sixteen patients were
excluded; 4 who were8 years of age and not felt to be able
to cooperate with the exercise protocol; 8 due to complex
intracardiac anatomy; and 4 due to a physical disability that
disallowed formal exercise testing (ET). Of the remaining
94, 11 patients were not contacted because they lived
outside of Ontario, 18 could not be contacted, and 28
patients did not wish to participate in the study. Two
patients had hemodynamically insignificant intracardiac ab-
normalities considered not to influence the study, along
with 15 patients with bicuspid aortic nonstenotic valves.
Thirty-seven patients agreed to participate in the study. Of
these, 6 patients failed to attend their appointments. As
such, 31 patients were recruited to participate in the study,
which included clinical and echocardiographic assessment,
ET and BP assessment, and 24-h ambulatory blood pressure
monitoring (ABPM). One patient who had ABPM moni-
toring failed to attend the exercise component of the
protocol. Surgical and interventional details, including an- vgiography, were reviewed to define arch measurements
following the most recent intervention, specifically the
minimum stent diameter and compared with published
normative data (15). Invasive gradients and follow-up arm
and leg BPs were documented to determine procedural
success. The study was approved by the institutional review
board and the research ethics committee, and informed,
written consent was obtained from all subjects.
Resting and exercise BP measurement and echocardio-
graphic assessment. Resting BPs were measured with a GE
inamap ProCare system (Critikon, Tampa, Florida), im-
ediately before a standardized recumbent bicycle staged
xercise study. Resting BP was recorded as an average of 2
eadings taken from the right arm sitting, over a 5- to
0-min period immediately before exercise, and from the
oncatheterized leg. All femoral pulses were easily palpable.
chocardiographic examinations
ere performed by 2 experi-
nced cardiac sonographers, us-
ng a Vivid 7 echocardiographic
ystem (GE Corp., Wauwatosa,
isconsin) with probe frequen-
ies selected as appropriate for
atient size. A full baseline
chocardiographic study was
erformed before exercise ac-
ording to our clinical standard
oarctation protocol, which in-
ludes apical 4-chamber, para-
ternal short-axis, and paraster-
al long-axis views, acquired
ccording to published guide-
ines. Left ventricular mass was
alculated according to the De-
ereux formula and indexed to
ody surface area. After the base-
ine echocardiographic study, an
xercise study was performed on a
eclining bike (Lode, Groningen, the Netherlands). During
xercise, peak gradients were recorded through the stented
orta using continuous-wave Doppler techniques.
BP measurement, electrocardiography (ECG), and stress
chocardiographic assessment was then performed on a
emirecumbent cycle ergometer during progressive exercise
n incremental stages. Bicycle pedaling was begun at 25 W
nd increased by 25 W every 2 min with the right arm BP
aken every 2 min during exercise using the Dinamap
ystem. The test was either symptom-limited (fatigue, chest
ain, ECG changes) or when the target heart rate (defined
s 80% of the maximal heart rate for age) was reached.
An abnormal systolic BP response to exercise (exagger-
ted absolute rise) or exercise-induced hypertension (EIH),
as defined using published normal adult and pediatric
Abbreviations
and Acronyms
ABPM  ambulatory blood
pressure monitoring
BP  blood pressure
BSA  body surface area
CoA  coarctation of the
aorta
ECG  electrocardiography
EIH  exercise-induced
hypertension
ET  exercise testing
LVMI  indexed left
ventricular mass
MASBP  mean ambulatory
systolic blood pressure
naCoA  native coarctation
reCoA  recurrent
coarctationalues as appropriate (see Results) (16–22). During exercise,
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194echocardiographic imaging was performed at each incre-
mental stage, in the transthoracic parasternal long- and
short-axis and apical views. Just before volitional fatigue as
indicated by the subject, the peak instantaneous pressure
Doppler gradient through the stent was reassessed in the
long-axis suprasternal view.
Ambulatory BP assessment. Spacelabs Ultralight or
pacelabs 90207 (Spacelabs, Issaquah, Washington) ABPM
onitors were used for 24-h BP assessment. Twenty-four–
our circadian variability (normal variability 10% between
aytime and nighttime values, so-called “dipping”), as well
s night and daytime mean systolic and diastolic BPs, were
ecorded. An appropriately sized cuff was placed on the
ight arm (no patient had an aberrant right subclavian
rtery), and the investigation was repeated if 85% of
ttempted readings were successful. Hypertension was de-
ned as either a 24-h mean ambulatory systolic BP
MASBP) of 95th percentile for sex and height or a
ystolic BP load (percentage of the 24-h period at 95th
ercentile) of 40% (18–22).
Statistical analysis. Data are presented as medians with
anges, or means with standard deviations, as appropriate.
omparison with published normal morphological data was
erformed for the study group as indicated using a 1-sample
test to assess the difference in means. Paired t tests were
used to assess changes in measured parameters in an
individual after an intervention and over time (e.g., between
stent intervention and study enrollment). For nonparamet-
ric data, the Mann–Whitney U test was used for unpaired
samples. and the Wilcoxon signed rank test for paired
samples. Correlation (Pearson coefficient) plots were per-
formed to assess correlation statistics in the datasets. Fisher
contingency tables were used to assess significant relation-
ships within categorical data. A p  0.05 was considered
statistically significant.
Results
Patient characteristics. Relevant demographics and clinical
details for each subject are listed in Table 1, and parameters
referring to the acute efficacy of the stent intervention are
presented in Table 2. Thirty-one patients with stented
reCoA (n  11) or naCoA (n  20) participated in the
tudy. Nine patients had balloon dilation or an additional
tent implantation to their lesion following the initial stent
rocedure. The median age at initial stent implantation was
3.1 years (range 4.5 to 17.8). The median follow-up (time
ince initial stent implantation) was 5.8 years (range 0.2 to
4.1), and median time from the last percutaneous proce-
ure to the study follow-up was 2.7 years (range 0.2 to
4.1). All stent procedures were clinically successful, with a
edian z-score for the minimum diameter of the stented
esion of 0.1 (3.0 to 3.2) (15). Acute invasive pull-back
radients following implantation were a mean 2.8  3.7 am Hg. Initial follow-up data (between 6 weeks and
months of intervention) were retrospectively available in
4 of the 31 patients, with the documented resting BP being
95th percentile for sex- and height-matched controls in
0 of 24 cases (42%). There was no significant difference in
emographics or clinical characteristics between those with
n naCoA or reCoA.
Resting and ambulatory BP monitoring. Resting BP ob-
tained before exercise identified 3 patients (9.7%) as hyper-
tensive (resting systolic BP 95th percentile for height), 2
of which were being treated for hypertension. The median
resting BP for the study group was at the 70.5 percentile
(range 0.1 to 99th percentile). The median right arm-to-leg
resting BP gradient was 1 mm Hg (range: 0 to 34 mm Hg).
Three patients were found to have a right arm-to-leg BP
gradient of 10 but 20 mm Hg; and 4 a gradient of 20
mm Hg.
Hypertension was identified on ABPM in 14 patients
(45%), by both a MASBP 95th percentile and increased
BP load of 40% (18,19,23–25). Masked hypertension
(hypertension found on ABPM analysis not recognized on
one-off office readings) was detected in 7 (26%) of the
cohort. Loss of BP circadian rhythm (dipping) was noted in
7 (23%) (Patients #18, #22, #23). The study groups’
MASBPs were clustered around the 78th percentile, the
level of divergence from the normal percentile spread being
significant (p  0.05). MASBP values and percentiles were
significantly higher than the corresponding resting one-off
systolic BP (mean difference 8.1 mm Hg; p  0.01, and
difference in paired means 5.6 percentile points, p  0.05);
(Fig. 1).
Effect of somatic growth on effective arch diameter. The
edian time from the most recent intervention on the CoA
tent, to the study date, was 2.7 years (range 0.2 to 14.1
ears). In most patients, significant somatic growth had
ccurred. The potential mismatch in stent size was assessed
y comparing reference values for growth of the aortic
sthmus related to height to stent diameter (15). For
atients who underwent significant somatic growth
10-cm height increase) from the time of the intervention
o the date of enrollment, the median stented arch diameter
ecreased from the 48th percentile to the 4th percentile
p  0.05) (Fig. 2). The mean individual decrease in
inimum effective diameter was 21.4 percentile points (p
.05) from the time of the last stent intervention. The
elationship between a minimum aortic diameter 5th
ercentile, and mean ABPM percentile is depicted in Figure 3.
atients with a smaller aortic stent diameter had a higher mean
BPM pressure, with a median difference of 4.2 percentile
oints, and a mean difference of 11.6 percentile points; how-
ver, this difference was not statistically significant.
Exercise BP analysis. Of the 4 patients with a resting systolic
rm-to-leg BP gradient of 20 mm Hg, none had an
dequate heart rate response to exercise, and 3 had EIH.
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195However, analysis of the resting BP gradient as a continuous
or a categorical variable did not correlate with the presence
of EIH. Subanalysis of those patients with ABPM hyper-
tension did not show a correlation with the exercise re-
sponse (Fig. 4), with the difference in the median systolic
pressure increase of 6 mm Hg (p  0.05). Similarly, there
as no relationship between those with a small stent
iameter and the presence of EIH.
Because this patient cohort spanned an adolescent to
oung adult age range, adult and pediatric normative data
ere applied to compare BP results (16,17,21,22).
ADULT DATA. In adults, EIH is defined as a peak systolic
BP of 220 mm Hg (which occurred in 9 of 31 patients
[30%]) or an increase in systolic BP of 60 mm Hg in men
Table 1. Patient Characteristics
Patient #
naCoA or
reCoA Sex
Age at Study
(yrs) Height (cm) Weight (k
1 reCoA M 23.1 172 76.7
2 naCoA M 19.3 176 79.2
3 naCoA M 19.8 179 62.6
4 naCoA M 14.1 162 52.9
5 reCoA M 24.1 173 92.4
6 naCoA M 8.1 135 33.8
7 naCoA M 19.8 170 83.2
8 naCoA M 10.3 140 33
9 naCoA M 9.9 136 37.7
10 naCoA F 26.7 159 82.6
11 naCoA M 14.2 159 71.6
12 naCoA M 17.0 173 58.8
13 reCoA M 16.7 180 73.7
14 naCoA M 15.6 176 75
15 reCoA M 15.2 171 71.4
16 naCoA M 15.6 177 61.5
17 reCoA F 13.3 159 60.1
18 reCoA M 11.7 138 41.1
19 naCoA F 18.3 160 58.6
20 naCoA M 20.7 182 81.3
21 reCoA M 28.3 178 86.8
22 naCoA M 16.3 179 90.8
23 naCoA M 17.5 176 71.1
24 reCoA M 21.4 186 80.5
25 reCoA M 16.7 168 58.6
26 naCoA M 19.1 169 72.3
27 reCoA M 17.6 180 95.4
28 naCoA F 27.4 167 89.4
29 reCoA M 15.2 166 62
30 naCoA M 22.0 176 72.5
31 naCoA F 13.9 152 48
Mean SD reCoA  11 M  26 17.7 5.0 167.4 14.1 68.2 17
Median (# range) naCoA  20 F  5 17.0 (8–28) 171 (135–186) 71.6 (33–95
ABPM ambulatory blood pressure monitoring; BP blood pressure; naCoAnative coarctation;and 50 mm Hg in women (which occurred in 24 patients s[80%]) (21,22). All those who had a peak exercise BP of
220 mm Hg also had an abnormally increased systolic
response. Of the 6 patients whose BP response was not
exaggerated, 5 had an inadequate exercise heart rate re-
sponse (1 on a beta-blocker), suggesting a suboptimal
nondiscriminatory exercise test. Thus, on the basis of adult
guidelines, all but 1 patient (who had a satisfactory exercise
test) had EIH.
PEDIATRIC DATA. Using published percentile data on nor-
mal bicycle exercise BP response in children (16,17), 11
patients (37%) had an exaggerated hypertensive exercise
response at 95th percentile (p  0.05).
Echocardiographic–BP correlations. Baseline echocardio-
raphic data are detailed in Table 3. Measurements of
Time From
Implant to
Study (yrs)
Arm-Leg BP
Gradient at
Study (mm Hg)
Resting RA BP
in mm Hg
(Percentile)
24-h Mean
ABPM Systolic
BP (Percentile)
Hypertensive
BP Load (%)
8.1 0.0 133 (84.3) 149 (99.9) 94
5.7 3.0 133 (84.5) 147 (99.9) 73.5
5.9 30.0 128 (70.5) 136 (97.1) 66.6
5.4 15.0 119 (75.5) 122 (83.8) 32.8
6.3 0.0 135 (88.4) 136 (98.1) 59.7
2.8 7.0 111 (87.4) 124 (98.2) 61.1
11.5 0.0 118 (35.1) 133 (96.8) 45.8
5.8 1.8 106 (62) 119 (91.8) 31.5
0.2 6.0 111 (80.4) 115 (85.4) 26.7
12.8 0.0 113 (15.2) 130 (97.3) 64.1
1.1 9.0 130 (95.7) 133 (98.8) 69.9
7.0 0.0 118 (46) 138 (99.0) 66.3
0.2 0.0 82 (0.1) 103 (0.8) 0
0.2 7.0 115 (48.1) 129 (88.5) 29.2
5.8 1.0 110 (33.6) 122 (69.4) 19.6
6.3 18.0 122 (72.8) 122 (61.7) 10.4
0.5 0.0 104 (33.4) 109 (30.8) 0
1.5 1.0 107 (55) 132 (99.8) 82.5
6.7 0.0 88 (0.11) 104 (11.1) 0
7.0 29.0 143 (97.5) 138 (98.4) 62
14.1 0.0 133 (87.6) 125 (67.6) 24.9
8.0 33.8 131 (90.2) 123 (58.8) 29.6
2.3 7.3 115 (32.3) 129 (88.5) 33.1
11.3 22.0 147 (99.1) 143 (99.6) 74.1
1.7 0.0 111 (25.4) 119 (55.1) 17.1
6.7 0.0 100 (2) 110 (14.7) 2
0.2 10.0 136 (93.2) 130 (86.6) 30
10.8 2.0 126 (80) 117 (69.4) 17.5
0.2 0.0 119 (66.4) 132 (97.5) 48.3
6.0 0.0 113 (19.5) 127 (82.7) 6.3
2.0 0.0 120 (82.9) 130 (99.8) 86.3
5.3 4 6.5 10 118.6 14.7 127 11.3 40.8 28.3
5.8 (0.2–14.1) 1.0 (0–34) 118 (88–147) 129 (104–149) 32.8 (0–94)
ght arm; reCoA recurrent coarctation.g)
.2
.4)ystolic cardiac function were all within normal limits, with
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196a mean fractional shortening of 42.2  6% and mean left
entricular ejection fraction of 72.4  7% (biplane Simp-
on’s calculation). There was a correlation (r  0.32; p 
.05) between resting continuous-wave Doppler flow gra-
ients through the stent (mean 31.2 9.4 mm Hg) and the
esting arm-to-leg BP gradient (mean 1.1  15 mm Hg).
he gradient also correlated with simultaneously recorded
esting right arm BP (r  0.39; p  0.05). Although there
as positive correlation between exercise arm-to-leg gradi-
nt, exercise BP, and ABPM percentile, none reached
tatistical significance.
Indexed left ventricular mass (LVMI) was calculated
rom both body surface area (BSA) and height (26–30). In
his cohort, the LVMI values correlated almost perfectly
Table 2. Acute Results of Stent Intervention
Patient #
Age at Implant
(yrs)
Stent
Manufacturer
and Model
Invasive Gradient Aft
Last Intervention
(mm Hg)
1 15.0 J&J P5014 8
2 13.6 J&J P5014 0
3 13.9 NuMed CP 45 mm 0
4 8.6 J&J P3110 4
5 17.8 J&J PG5910 14
6 5.3 NuMed CP 28 mm 0
7 8.2 J&J PG5910 0
8 4.5 J&J PG3910 7
9 9.7 NuMed CP 34 mm 0
10 13.9 J&J P5014 0
11 13.1 NuMed CP 39 mm 10
12 10.0 J&J PG2910 0
13 16.4 J&J 4,014 XL 7
14 15.5 Atrium V12 3
15 9.4 J&J PG2910 8
16 9.3 J&J PG3910 4
17 12.8 J&J P4014 0
18 10.2 J&J P3110 1
19 11.6 J&J PG2910 5
20 13.7 J&J PG5910 0
21 14.2 J&J P4014 4
22 8.3 J&J P308 0
23 15.2 J&J P4014 1
24 10.1 J&J P5014 0
25 15.0 J&J P3110 1
26 12.4 J&J P5014 0
27 17.4 Atrium V12 0
28 16.6 J&J P5014 0
29 15.0 NuMed CP 45 mm 0
30 16.0 J&J P5014 4
31 11.9 NuMed CP 34 mm 7
Mean SD 12.4 3.3 2.8 3.7
Median (range) 13.1 (4.5 to 18.8) 1 (0 to 14)
NuMed CP were covered stents. *Data points that were unavailable or of uncertain accuracy.
BP blood pressure; J&J Johnson and Johnson.sing either normalization (r  0.96; p  0.001), and sherefore, given the young adult age range at exercise
esting, we elected to use the more recognized BSA nor-
alization for adults in our calculations (28,29). As such,
VMI was increased with a mean of 91.3  24.5 g/m2
compared with the normal mean value for men of 61  10
g/m2 or 47  7 g/m2 for women (p  0.05). LVMI
ositively correlated with the peak exercise BP (r  0.51;
 0.05) (Fig. 5), whereas the MASBP percentiles trended
ith LVMI, but without statistical significance. From the
VMI data, 5 patients were classified as having left ven-
ricular hypertrophy, and of those, only 1 had an increased
elative wall thickness, the remainder of the cohort (hyper-
rophied and nonhypertrophied) having normal ratios (27).
Recurrent versus native coarctation. The average age at
-Score of Coarctation
Diameter Before
Stent Implant
z-Score of Minimum
Stent Diameter at
Time of Implant
Arm-Leg BP Gradient (mm Hg)
at First Follow-Up
After Implant
4.5 2.4 0.0
1.2 1.3 0.0
6.6 1.1 *
5.5 0.7 4.0
2.2 0.2 16.0
12.8 1.5 0.0
0.7 3.2 0.0
4.4 1.1 *
4.8 0.8 10.0
3.6 0.1 0.0
4.4 0.1 8.0
2.9 0.0 *
4.0 0.1 *
4.6 0.3 *
7.1 1.5 2.0
9.8 0.1 0.0
3.8 1.1 *
7.2 2.6 9.0
3.0 0.8 *
3.1 1.1 10.0
2.7 0.2 2.0
3.9 1.5 0.0
3.8 0.1 0.0
1.7 1.9 0.0
2.7 0.2 0.0
3.6 1.2 *
1.9 0.1 10.0
5.2 0.5 *
3.4 0.8 0.0
3.2 0.9 0.0
19.2 3.0 *
4.8 3.6 0.2 1.3 3.4 4.9
3.8 (19.2 to 0.7) 0.1 (3.0 to 3.2) 0 (0 to 16)er ztent implantation and the interval between stent interven-
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197tion and the study protocol were similar for both reCoA and
naCoA patients. The invasive pull-back gradients before
intervention were statistically different between the 2 sub-
groups (mean 22.8 mm Hg [reCoA] vs. 12.3 mm Hg
[naCoA]; p  0.05). However, there was no difference in
residual pull-back gradients (3.6 mm Hg [naCoA]) vs. 2.6
mm Hg [reCoA]) after the intervention. Similarly, there
was no significant difference in peak exercise BP response or
mean ABPM percentiles between the 2 groups, or the
proportion of those meeting criteria for hypertension on
ABPM, which was approximately 45% in either group.
Discussion
Over the last decade, the literature on repaired coarctation
has shown that freedom from residual hypertension is not
related to freedom from residual obstruction. The cause of
this tendency to hypertension is still under debate, with
hypotheses involving the presence of an inherent arteriopa-
thy, arterial stiffness induced by chronic shear stress, and
abnormal flow or abnormal renal homeostasis as potential
contributions (11,14–20,31).
Our data show that in a dichotomous pediatric popula-
tion containing both patients with stented native and
recurrent coarctation after surgical repair, ambulatory and
exercise hypertension are detectable sequelae despite the
lack of early or long-term residual or recurrent obstruction.
The presence of hypertension was not predictable from
baseline procedural characteristics, such as duration of
coarctation before definitive treatment, length of follow-up
Figure 1. Comparison of “One-Off” BP With ABPM Mean Systolic Percentiles
Comparison of “one-off” resting systolic blood pressure (BP) percentiles
(median 70.5; range 0.1 to 99) with ambulatory blood pressure monitoring
(ABPM) mean systolic percentiles (median 84.5; range 6 to 99). Difference
in paired means, 15.6 percentile points (p  0.05).after intervention, or degree of pre-procedural isthmalhypoplasia. Pre-existent arch hypoplasia has been impli-
cated as a substrate for persistent ambulatory and exercise-
induced hypertension, but this was not observed in this
cohort, with no correlation between BSA-indexed trans-
verse arch caliber, ABPM percentile or exercise BP (14,32).
Indeed, the prevalence of significant hypertension through-
out the cohort made the statistical identification of predis-
posing factors difficult.
Placing a nondistensible metal stent into a growing aorta
is an understandable cause for concern. These data under-
score that following successful stenting in childhood,
growth into adulthood may occur without signs of residual
or progressive arch obstruction at rest. As such, body size
may more than double from the time of initial stent
placement to adulthood, leaving the aortic stent an area of
fixed hypoplasia. For those patients who had undergone
significant somatic growth since the intervention, there was
a significant decrease in the corrected minimum stent
diameter (p  0.05). There was also a trend between the
indexed stent diameter and the presence of hypertension
on ABPM between the group with a small aortic arch
(5th percentile) and those with normal arch diameters.
Figure 2. z-Score of the Minimum Stent Diameter in Patients
With Significant Somatic Growth
Decrease in z-score of the minimum stent diameter in patients with signiﬁ-
cant somatic growth since intervention (10-cm increase in height). The
z-score decreased by a mean of 1.36 (p  0.05).
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198This finding suggests that once implanted, the stent
should be carefully monitored and electively dilated
according to the patient’s growth, despite the absence of
a resting gradient, to avoid the development or progres-
sion of hypertension.
The presence of EIH (24 of 25 adequate studies) did not
correlate with resting systolic BP, stent diameter, or the
presence of ABPM hypertension. These observations are
consistent with the postulate that an abnormal exercise
response represents a combination of abnormal BP homeo-
stasis due to an inherent vasculopathy, sympathetic overac-
tivity, and the presence of an abnormal arch segment, that
is, the stent. There is no evidence that the incidence of EIH
is higher in stented patients versus those with surgical repair
as discussed in other studies; however, these 2 populations
are often so distinct with respect to age, clinical history, and
management pathways that a comparison on this point is
almost impossible (33).
What is clear from our data and that of others is that
systemic hypertension is underinvestigated, underdiag-
nosed, and undertreated in this at-risk population (34).
Indeed, many of our patients had significant hypertension
on ABPM as opposed to one-off office BP checks. We
would recommend that periodic ABPM monitoring be a
routine practice in the long-term follow-up of all patients
with “corrected” coarctation.
Echocardiographic data also noted that continuous-wave
Doppler velocities through the stented area could be useful
in predicting the presence of EIH or ABPM hypertension.
A longitudinal study of continuous-wave Doppler velocities
and their correlation with ABPM was beyond the scope of
this study; we would suggest that a high continuous-wave
Figure 3. Comparison of ABPM Percentiles by Stent Diameter
Comparison of ambulatory blood pressure monitoring (ABPM) percentiles
for patients with a minimum stent diameter 5th percentile (median 82.5;
range 8 to 99) versus those with diameters 5th percentile (median 96.1;
range 6 to 99.6). Mean difference 11.6 percentile points.Doppler velocity or a velocity that is serially increasingshould trigger a more thorough investigation of the
possible presence of systemic hypertension. The actual
cutoff point at which the stent velocity becomes signifi-
cant is not clear.
Blood pressure load on ABPM assessment is indepen-
dently associated with an increased LVMI (35,36), and may
therefore be a more relevant clinical parameter than the
standard mean BP calculation (19,37). In this study, all
patients whose mean ambulatory BPs were 95th percen-
ile had a hypertensive BP load 40%, and 5 solely had a
igh BP load. As such, the incidence of systemic hyperten-
ion may be higher than compared to historical data, which
ay not have assessed BP load.
The clinical relevance of EIH in the coarctation popula-
ion has been questioned in the literature, but without
omprehensive normal data, it is difficult to base clinical
nd/or interventional decisions solely on this finding. A
ignificant proportion of this cohort had EIH on the basis of
oth adult and pediatric criteria, further supporting the
heory that patients with an adequate anatomic correction
till have abnormal BP homeostasis. We also found a
ositive correlation between exercise BP and LVMI, which
dditionally underscores the detrimental effects of exercise
ypertension on the cardiovascular system.
Previous studies addressing stenting of reCoA or naCoA
ave focused on adult populations, with little data available
n the fate of those who have the procedure done in the
ediatric age group. Some authors suggest that the propen-
ity to hypertension may be related to the chronicity of an
ncorrected obstruction, and therefore, patients who have
heir obstructive gradient abolished in childhood are more
ikely to remain normotensive. Our data do not give
Figure 4. Comparison of Systolic BP Response to Exercise
Comparison of systolic BP response to exercise in those hypertensive on
ABPM (median 90; range 14 to 121) versus those normotensive (median
84; range 8 to 135). Median difference in systolic response 6 mm Hg
(p  0.05). Abbreviations as in Figure 1.
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199credence to this assertion and support the hypotheses
identifying persistent hypertension as a pre-programmed
disorder related to an intrinsic vasculopathy and/or associ-
ated renal dysfunction.
Study limitations. The main limitations of this study are
elated to the sample size and heterogeneity of the sample.
he duration since stent implantation was widely variable
ithin the sample, limiting the ability to fully assess the
ong-term effects of stents on the presence, degree, and
anagement of hypertension. The study also highlights the
ifficulty in statistical analysis of patients moving from
hildhood to adulthood (38). There was a relative lack of
ormal data covering this period, making longitudinal
Table 3. Echocardiographic Variables
Patient #
Fractional
Shortening (%)
Ejection
Fraction (%)
LVPWd (mm)
(z-Score)
IVSd (m
(z-Scor
1 37 67 0.83 (0.5) 0.78 (0)
2 55 85 0.78 (0) 1.02 (2.1)
3 46 77 0.91 (1.3) 1.18 (3.55
4 48 79 0.81 (1) 0.64 (0
5 46 77 1 (1.5) 1.43 (4.6)
6 50 81 0.63 (0.3) 0.74 (1.33
7 33 61 0.88 (0.82) 0.95 (1.5)
8 39 69 0.5 (1.3) 0.4 (3
9 56 87 0.62 (0) 0.73 (1)
10 43 74 0.6 (1.5) 0.92 (1.45
11 51 82 0.68 (0.5) 0.94 (1.82
12 — — — —
13 43 74 0.85 (0.6) 0.64 (1
14 43 73 0.93 (1.3) 0.81 (0.8)
15 38 68 0.74 (0.1) 0.71 (0
16 38 68 0.72 (0.2) 0.75 (0)
17 — — — —
18 38 68 0.78 (1.4) 0.74 (1)
19 32 59 0.63 (0.8) 0.74 (0.2)
20 46 76 1.09 (2.1) 1.18 (3.1)
21 38 67 1 (1.5) 0.93 (1.2)
22 44 74 1.05 (1.8) 0.83 (0.2)
23 37 66 0.85 (0.7) 1.07 (2.6)
24 36 65 0.78 (0.1) 0.74 (0.6)
25 44 75 0.78 (0.5) 1.07 (3.1)
26 35 64 0.68 (0.7) 0.78 (0.2)
27 41 71 0.84 (0.2) 0.7 (1
28 48 80 1.03 (1.8) 0.84 (0.5)
29 37 66 0.81 (0.7) 0.97 (2.2)
30 37 67 0.93 (1.3) 0.99 (2)
31 — — — —
Mean SD 42.2 6.1 72.4 7 0.81 0.14 0.86
Median (# range) 42 (32–56) 72 (59–87) 0.81 (0.5–1.09) 0.82 (0.4–
IVSd diastolic interventricular septal thickness; LVEDD left ventricular end-diastolic dimension
ventricular posterior wall thickness; RWT relative wall thickness [(2 LVPWd)/LVEDd]. One patie
for detailed analysis.nalysis challenging.onclusions
The risk of hypertension is not relieved by the removal of a
measurable gradient in CoA. The chronic burden of hyperten-
sion in coarctation patients is likely significantly higher than in
other at-risk populations due to the early onset of the illness.
This population needs to be treated as particularly high risk in
this respect, and hypertension should be aggressively sought
and treated. The study emphasizes the need for close follow-up
of patients who have had angiographically successful correction
of CoA. As yet, no satisfactory theory explaining the origin of
hypertension in coarctation exists, but whatever the mecha-
nism, it remains a major issue requiring careful lifelong review,
LVEDD (mm)
(z-Score) RWT LVMi (g/m2) Hypertension LVH
5.07 (0.1) 0.32 73.87 Yes No
5.32 (0.4) 0.34 89.80 Yes No
5.66 (1.8) 0.37 132.30 Yes Yes
5.09 (1.2) 0.28 79.68 No No
5.54 (0.6) 0.44 135.93 Yes Yes
4.84 (2.1) 0.28 93.90 Yes No
5.69 (1.36) 0.32 103.28 Yes No
4.8 (2.2) 0.19 54.87 No No
3.96 (0.8) 0.34 62.11 No No
5.12 (0.2) 0.30 71.64 Yes No
5.92 (2.6) 0.27 106.07 Yes No
— — Yes
5.87 (1.9) 0.25 85.07 No No
5.41 (0.3) 0.32 90.52 No No
5.29 (0.7) 0.27 72.12 No No
4.67 (0.8) 0.31 61.49 No No
— — No
3.69 (2.1) 0.41 61.63 Yes No
4.54 (0.7) 0.30 58.84 No No
6.09 (2.1) 0.37 147.46 Yes Yes
6.13 (2.1) 0.31 119.30 No Yes
5.7 (0.9) 0.33 99.54 No No
5.54 (1.2) 0.35 109.49 No No
6.14 (2.1) 0.25 88.77 Yes No
5.22 (1.1) 0.35 105.96 No No
5.28 (0.7) 0.28 72.73 No No
6.06 (1.7) 0.25 83.97 No No
5.09 (0.3) 0.37 86.47 No No
5.91 (2.8) 0.30 122.66 Yes Yes
4.9 (0.6) 0.39 88.46 No No
— — — — —
5.3 0.6 0.32 0.05 91.3 24.5
5.3 (3.7–6.1) 0.32 (0.19–0.44) 88.6 (54.9–147.5)
left ventricular hypertrophy; LVMi left ventricular mass index (see text); LVPWd diastolic left
to attend for the complete echo protocol and in 2 patients the echo data was deemed inadequatem)
e)
)
.9)
)
.6)
)
)
.58)
.6)
.2)
0.2
1.4)
; LVH
nt failedregardless of the age of repair.
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